Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Low-intensity cytoreduction with low-dose cytarabine prior to blinatumomab for pediatric and AYA R/R ALL integrated with multi-omics analysis to discover predictive biomarkers: Initial results from JPLSG-ALL-R19-blin

Itaru Kato, Takashi Mikami, Yuta Kawahara, Hirokazu Kobushi, Hiroya Hashimoto, Akiko Saito, Shohei Yamamoto, Hidemi Toyoda, Hiroaki Goto

Blood (2025) 146 (Supplement 1): 1583.

https://doi.org/10.1182/blood-2025-1583

Published: 2025

Journal Articles

Comparable efficacy of CR, CRh, and CRi in pediatric acute myeloid leukemia: A report from the Japan Children's Cancer Group

Blood (2025) 146 (Supplement 1): 3512.

https://doi.org/10.1182/blood-2025-3512

Published: 2025

Journal Articles

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukemia in the chronic phase: Result of JALSG CML RE-STOP219 study.

Blood (2025) 146 (Supplement 1): 5546.

https://doi.org/10.1182/blood-2025-5546

Published: 2025

Journal Articles

Five-year interim analysis of multi-institutional collaborative study for estimating the persistence of treatment free remission in chronic myeloid leukemia after stopping tyrosine kinase inhibitor in Japan: J-SKI

Blood (2025) 146 (Supplement 1): 5545.

https://doi.org/10.1182/blood-2025-5545

Published: 2025

Journal Articles

A Phase 2 study of sequential administration of gilteritinib after MEC chemotherapy in Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia in adults: Japan adult leukemia study group (JALSG) RR-FLT3-AML220 study

Blood (2025) 146 (Supplement 1): 998.

https://doi.org/10.1182/blood-2025-998

Published: 2025

Journal Articles

Impact of asparaginase discontinuation on outcomes in pediatric B-cell precursor acute lymphoblastic leukemia: Post hoc analysis of the JCCG ALL-B12 Study

Blood (2025) 146 (Supplement 1): 5119.

https://doi.org/10.1182/blood-2025-5119

Published: 2025

Journal Articles

Overall Survival in Acquired Pure Red Cell Aplasia in Adults Following Immunosuppressive Therapy: Preliminary Results from the Nationwide Cohort Study (PRCA2016)

Naohito Fujishima, MD, Makoto Hirokawa, MD PhD, Kenichi Sawada, MD, Shinji Nakao, MD PhD, Yuji Yonemura, MD PhD, Akira Matsuda, MD, Norio Komatsu, MD PhD, Hideo Harigae, MD, Akiko Saito, MD, Kaoru Tohyama, MD, Itaru Matsumura, MD, Mineo Kurokawa, MD PhD, Shunya Arai, MD PhD, Kinuko Mitani, MD

Blood (2018) 132 (Supplement 1): 2593.

https://doi.org/10.1182/blood-2018-99-114245

Published: 2018

Journal Articles

Phase II Trial of CH5424802 (alectinib hydrochloride) for Recurrent or Refractory ALK-Positive Anaplastic Large Cell Lymphoma

Masahiro Sekimizu, MD PhD, Reiji Fukano, MD PhD, Ilseung Choi, MD PhD, Akiko Kada, PhD, Akiko Saito, MD, Ryuta Asada, PhD, Tetsuya Mori, MD PhD, Hirokazu Nagai, MD PhD

Blood (2018) 132 (Supplement 1): 2924.

https://doi.org/10.1182/blood-2018-99-112708

Published: 2018

Journal Articles

Negative CD19 Expression Is Associated with Inferior Relapse-Free Survival in RUNX1-RUNX1T1 -Positive Acute Myeloid Leukemia; The Japanese Pediatric Leukemia/Lymphoma Study Group Experience from the AML-05 Study

Toshihiko Imamura, MD PhD, Kenichi Sakamoto, MD PhD, Norio Shiba, MD PhD, Takao Deguchi, MD PhD, Nobutaka Kiyokawa, MD PhD, Yoshiko Hashii, MD, PhD, Akiko Saito, MD, Daisuke Tomizawa, MD PhD, Takashi Taga, MD PhD, Souichi Adachi, MD PhD

Blood (2018) 132 (Supplement 1): 2810.

https://doi.org/10.1182/blood-2018-99-115553

Published: 2018

Journal Articles

Attempts to Optimize Post-Induction Treatment in Childhood Acute Myeloid Leukemia without Core Binding Factors: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

Blood (2012) 120 (21): 3545.

https://doi.org/10.1182/blood.V120.21.3545.3545

Published: 2012

Journal Articles

Acute Lymphoblastic Leukemia in Japanese Adolescents; Biology and Toxicity Profile

So-ichi Suenobu, MD, PhD, Atsushi Sato, MD, Yoshihiro Takahashi, MD, PhD, Ikuya Usami, MD, PhD, Shin-ichiro Nishimura, MD, PhD, Daiichiro Hasegawa, MD, PhD, Yoshiko Hashii, MD, PhD, Nobuhiro Suzuki, MD, PhD, Akiko Saito, MD, PhD, Hirohide Kawasaki, MD, Keiko Yagi, MD, Keizo Horibe, MD, Junichi Hara, MD, PhD, Hiroki Hori, MD, Megumi Oda, MD

Blood (2012) 120 (21): 4290.

https://doi.org/10.1182/blood.V120.21.4290.4290

Published: 2012

Journal Articles

Myelodysplasia-Related Changes Have Adverse Prognostic Significance in Children with Acute Myeloid Leukemia; A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

Akitoshi Kinoshita, MD, Hayato Miyachi, MD, PhD, Hiromichi Matsushita, MD, PhD, Miharu Yabe, MD, PhD, Tomohiko Taki, MD, PhD, Tomoyuki Watanabe, PhD, Akiko Saito, MD, PhD, Daisuke Tomizawa, Nobutaka Kiyokawa, MD, PhD, Takashi Taga, MD, Takao Deguchi, MD, Yoshiko Hashii, MD, PhD, Kiminori Terui, MD, PhD, Hiroyuki Takahashi, MD, PhD, Yasuhide Hayashi, MD, PhD, Akio Tawa, MD, PhD, Keizo Horibe, MD, Souichi Adachi, MD, PhD

Blood (2012) 120 (21): 2583.

https://doi.org/10.1182/blood.V120.21.2583.2583

Published: 2012

Journal Articles

Refractory / Relapsed Myeloid Leukemia of Down Syndrome Is Resistant to Second-Line Chemotherapy and Hardly Salvaged by Hematopoietic Stem Cell Transplantation: A Retrospective Study by the Japanese Pediatric Leukemia / Lymphoma Study Group (JPLSG)

Takashi Taga, MD, PhD, Akiko Saito, MD, PhD, Kazuko Kudo, MD, PhD, Daisuke Tomizawa, MD, Kiminori Terui, MD, PhD, Hiroshi Moritake, MD, PhD, Akitoshi Kinoshita, MD, PhD, Shotaro Iwamoto, MD, PhD, Hideki Nakayama, MD, Hiroyuki Takahashi, MD, PhD, Akio Tawa, MD, PhD, Akira Shimada, MD, PhD, Tomohiko Taki, MD, PhD, Hisato Kigasawa, MD, Katsuyoshi Koh, MD, Souichi Adachi, MD, PhD

Blood (2011) 118 (21): 4276.

https://doi.org/10.1182/blood.V118.21.4276.4276

Published: 2011

Journal Articles

Nation-Wide Survey of Relapsed Infantile Acute Lymphoblastic Leukemia In Japan: Treatment and Outcome From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) MLL03 Study.

Takako Miyamura, MD, PhD, Katsuyoshi Koh, MD, Daisuke Tomizawa, MD, Takashi Sato, MD, PhD, Koji Kato, MD, PhD, Kanji Sugita, MD, PhD, Masahiro Hirayama, MD, Atsushi Ogawa, MD, Yoshihiro Takahashi, MD, Ryosei Nishimura, MD, PhD, Hidemasa Ochiai, MD, Yuko Nomura, MD, Akiko Saito, MD, PhD, Masahito Tsurusawa, MD, PhD, Keizo Horibe, MD, PhD, Eiichi Ishii, MD, PhD

Blood (2010) 116 (21): 1025.

https://doi.org/10.1182/blood.V116.21.1025.1025

Published: 2010

Journal Articles

Low frequency of CD94/NKG2A + T lymphocytes in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers

Mineki Saito, Veronique M. Braud, Peter Goon, Emmanuel Hanon, Graham P. Taylor, Akiko Saito, Nobutaka Eiraku, Yuetsu Tanaka, Koichiro Usuku, Jonathan N. Weber, Mitsuhiro Osame, Charles R. M. Bangham

Blood (2003) 102 (2): 577–584.

https://doi.org/10.1182/blood-2002-09-2855

Published: 2003

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Low-intensity cytoreduction with low-dose cytarabine prior to blinatumomab for pediatric and AYA R/R ALL integrated with multi-omics analysis to discover predictive biomarkers: Initial results from JPLSG-ALL-R19-blin

Comparable efficacy of CR, CRh, and CRi in pediatric acute myeloid leukemia: A report from the Japan Children's Cancer Group

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukemia in the chronic phase: Result of JALSG CML RE-STOP219 study.

Five-year interim analysis of multi-institutional collaborative study for estimating the persistence of treatment free remission in chronic myeloid leukemia after stopping tyrosine kinase inhibitor in Japan: J-SKI

A Phase 2 study of sequential administration of gilteritinib after MEC chemotherapy in Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia in adults: Japan adult leukemia study group (JALSG) RR-FLT3-AML220 study

Impact of asparaginase discontinuation on outcomes in pediatric B-cell precursor acute lymphoblastic leukemia: Post hoc analysis of the JCCG ALL-B12 Study

Overall Survival in Acquired Pure Red Cell Aplasia in Adults Following Immunosuppressive Therapy: Preliminary Results from the Nationwide Cohort Study (PRCA2016)

Phase II Trial of CH5424802 (alectinib hydrochloride) for Recurrent or Refractory ALK-Positive Anaplastic Large Cell Lymphoma

Negative CD19 Expression Is Associated with Inferior Relapse-Free Survival in RUNX1-RUNX1T1 -Positive Acute Myeloid Leukemia; The Japanese Pediatric Leukemia/Lymphoma Study Group Experience from the AML-05 Study

Attempts to Optimize Post-Induction Treatment in Childhood Acute Myeloid Leukemia without Core Binding Factors: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

Acute Lymphoblastic Leukemia in Japanese Adolescents; Biology and Toxicity Profile

Myelodysplasia-Related Changes Have Adverse Prognostic Significance in Children with Acute Myeloid Leukemia; A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

Refractory / Relapsed Myeloid Leukemia of Down Syndrome Is Resistant to Second-Line Chemotherapy and Hardly Salvaged by Hematopoietic Stem Cell Transplantation: A Retrospective Study by the Japanese Pediatric Leukemia / Lymphoma Study Group (JPLSG)

Nation-Wide Survey of Relapsed Infantile Acute Lymphoblastic Leukemia In Japan: Treatment and Outcome From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) MLL03 Study.

Low frequency of CD94/NKG2A + T lymphocytes in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only